{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:16:44Z","timestamp":1793114204195,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41416-018-0233-4","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T06:51:24Z","timestamp":1534834284000},"page":"724-736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma"],"prefix":"10.1038","volume":"119","author":[{"given":"Aisha A.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tymour","family":"Forouzanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bloemena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JGAM","family":"de Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud H.","family":"Brakenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ren\u00e9","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco N.","family":"Helder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"233_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","volume":"26","author":"N Vigneswaran","year":"2014","unstructured":"Vigneswaran, N. & Williams, M. D. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral. Maxillofac. Surg. Clin. North. Am. 26, 123\u2013141 (2014).","journal-title":"Oral. Maxillofac. Surg. Clin. North. Am."},{"key":"233_CR2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1601-0825.2006.01349.x","volume":"13","author":"SK Mithani","year":"2007","unstructured":"Mithani, S. K., Mydlarz, W. K., Grumbine, F. L., Smith, I. M. & Califano, J. A. Molecular genetics of premalignant oral lesions. Oral. Dis. 13, 126\u2013133 (2007).","journal-title":"Oral. Dis."},{"key":"233_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.oraloncology.2017.02.019","volume":"67","author":"JE Tota","year":"2017","unstructured":"Tota, J. E. et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral. Oncol. 67, 146\u2013152 (2017).","journal-title":"Oral. Oncol."},{"key":"233_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1601-0825.2000.tb00105.x","volume":"6","author":"SR Moore","year":"2000","unstructured":"Moore, S. R., Johnson, N. W., Pierce, A. M. & Wilson, D. F. The epidemiology of tongue cancer: a review of global incidence. Oral. Dis. 6, 75\u201384 (2000).","journal-title":"Oral. Dis."},{"key":"233_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2017.05.026","volume":"82","author":"AA Hussein","year":"2017","unstructured":"Hussein, A. A. et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur. J. Cancer 82, 115\u2013127 (2017).","journal-title":"Eur. J. Cancer"},{"key":"233_CR6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner, H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360, 1131\u20131135 (2002).","journal-title":"Lancet"},{"key":"233_CR7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski, C. H., Schmidt, B. L. & Jordan, R. C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20\u201344 years. Cancer 103, 1843\u20131849 (2005).","journal-title":"Cancer"},{"key":"233_CR8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1368-8375(02)00142-2","volume":"39","author":"P O-charoenra","year":"2003","unstructured":"O-charoenra, P. et al. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol. 39, 386\u2013390 (2003).","journal-title":"Oral Oncol."},{"key":"233_CR9","unstructured":"Klausner R. D. The Nation\u2019s Investment in Cancer Research: A Plan and Budget Proposal for fiscal year 2003. The National Cancer Institute, Bethesda, MD, 2002. https:\/\/www.cancer.gov\/about-nci\/budget\/about-annual-plan\/nci-plan-2002.pdf"},{"key":"233_CR10","first-page":"129","volume":"132","author":"AN Bhatt","year":"2010","unstructured":"Bhatt, A. N., Mathur, R., Farooque, A., Verma, A. & Dwarakanath, B. S. Cancer biomarkers\u2014current perspectives. Indian J. Med. Res. 132, 129\u2013149 (2010).","journal-title":"Indian J. Med. Res."},{"key":"233_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","volume":"13","author":"M Comabella","year":"2014","unstructured":"Comabella, M. & Montalban, X. Body fluid biomarkers in multiple sclerosis. Lancet Neurol. 13, 113\u2013126 (2014).","journal-title":"Lancet Neurol."},{"key":"233_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrneurol.2015.173","volume":"11","author":"CE Teunissen","year":"2015","unstructured":"Teunissen, C. E., Malekzadeh, A., Leurs, C., Bridel, C. & Killestein, J. Body fluid biomarkers for multiple sclerosis\u2014the long road to clinical application. Nat. Rev. Neurol. 11, 585\u2013596 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"233_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane, L. M. et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br. J. Cancer 93, 387\u2013391 (2005).","journal-title":"Br. J. Cancer"},{"key":"233_CR14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","volume":"61","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt, P. M. et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin. Chem. 61, 1446\u20131452 (2015).","journal-title":"Clin. Chem."},{"key":"233_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijom.2010.12.003","volume":"40","author":"LR Oliveira","year":"2011","unstructured":"Oliveira, L. R. & Ribeiro-Silva, A. Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int. J. Oral. Maxillofac. Surg. 40, 298\u2013307 (2011).","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"233_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jcmm.12650","volume":"20","author":"X Yu","year":"2016","unstructured":"Yu, X. & Li, Z. MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma. J. Cell. Mol. Med. 20, 10\u201316 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"233_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-017-7215-0_2","volume":"867","author":"A Mordente","year":"2015","unstructured":"Mordente, A., Meucci, E., Martorana, G. E. & Silvestrini, A. Cancer biomarkers discovery and validation: state of the art, problems and future perspectives. Adv. Exp. Med. Biol. 867, 9\u201326 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"233_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1373\/clinchem.2012.184614","volume":"59","author":"MP Pavlou","year":"2013","unstructured":"Pavlou, M. P., Diamandis, E. P. & Blasutig, I. M. The long journey of cancer biomarkers from the bench to the clinic. Clin. Chem. 59, 147\u2013157 (2013).","journal-title":"Clin. Chem."},{"key":"233_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2005.06.005","volume":"42","author":"X Huang","year":"2006","unstructured":"Huang, X. et al. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral. Oncol. 42, 26\u201331 (2006).","journal-title":"Oral. Oncol."},{"key":"233_CR20","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-05-2412","volume":"12","author":"R Nagler","year":"2006","unstructured":"Nagler, R., Bahar, G., Shpitzer, T. & Feinmesser, R. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin. Cancer Res. 12, 3979\u20133984 (2006).","journal-title":"Clin. Cancer Res."},{"key":"233_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00784-010-0404-z","volume":"15","author":"B Rai","year":"2011","unstructured":"Rai, B., Kaur, J., Jacobs, R. & Anand, S. C. Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin. Oral. Investig. 15, 347\u2013349 (2011).","journal-title":"Clin. Oral. Investig."},{"key":"233_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1155\/2012\/926703","volume":"32","author":"A Suresh","year":"2012","unstructured":"Suresh, A. et al. Resistance\/response molecular signature for oral tongue squamous cell carcinoma. Dis. Markers 32, 51\u201364 (2012).","journal-title":"Dis. Markers"},{"key":"233_CR23","first-page":"207","volume":"27","author":"A Lotfi","year":"2015","unstructured":"Lotfi, A. et al. Serum level of interleukin-6 in patients with oral tongue squamous cell carcinoma. Iran. J. Otorhinolaryngol. 27, 207\u2013211 (2015).","journal-title":"Iran. J. Otorhinolaryngol."},{"key":"233_CR24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bjoms.2004.11.020","volume":"43","author":"X Li","year":"2005","unstructured":"Li, X., Qiao, Z., Long, X., Wei, J. & Cheng, Y. Serum concentration of AMDL DR-70 for the diagnosis and prognosis of carcinoma of the tongue. Br. J. Oral. Maxillofac. Surg. 43, 513\u2013515 (2005).","journal-title":"Br. J. Oral. Maxillofac. Surg."},{"key":"233_CR25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/cas.12077","volume":"104","author":"XH Guo","year":"2013","unstructured":"Guo, X. H. et al. Decreased adiponectin level is associated with aggressive phenotype of tongue squamous cell carcinoma. Cancer Sci. 104, 206\u2013213 (2013).","journal-title":"Cancer Sci."},{"key":"233_CR26","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1002\/lary.25812","volume":"126","author":"MS Shegefti","year":"2016","unstructured":"Shegefti, M. S. et al. Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma. Laryngoscope 126, E191\u2013E195 (2016).","journal-title":"Laryngoscope"},{"key":"233_CR27","first-page":"237","volume":"13","author":"JM Bhatavdekar","year":"1993","unstructured":"Bhatavdekar, J. M., Patel, D. D., Vora, H. H. & Balar, D. B. Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study. Anticancer Res. 13, 237\u2013240 (1993).","journal-title":"Anticancer Res."},{"key":"233_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000217825","volume":"14","author":"JM Bhatavdekar","year":"1993","unstructured":"Bhatavdekar, J. M., Patel, D. D., Vora, H. H. & Balar, D. B. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol. 14, 55\u201358 (1993).","journal-title":"Tumour Biol."},{"key":"233_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jso.2930570209","volume":"57","author":"JM Bhatavdekar","year":"1994","unstructured":"Bhatavdekar, J. M. et al. Prolactin: its role in advanced tongue cancer. J. Surg. Oncol. 57, 115\u2013120 (1994).","journal-title":"J. Surg. Oncol."},{"key":"233_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<257::AID-HED8>3.0.CO;2-K","volume":"22","author":"JM Bhatavdekar","year":"2000","unstructured":"Bhatavdekar, J. M. et al. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head. Neck 22, 257\u2013264 (2000).","journal-title":"Head. Neck"},{"key":"233_CR31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oraloncology.2011.02.006","volume":"47","author":"A Korostoff","year":"2011","unstructured":"Korostoff, A., Reder, L., Masood, R. & Sinha, U. K. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral. Oncol. 47, 282\u2013287 (2011).","journal-title":"Oral. Oncol."},{"key":"233_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oraloncology.2017.07.003","volume":"72","author":"C Rivera","year":"2017","unstructured":"Rivera, C., Oliveira, A. K., Costa, R. A. P., De Rossi, T. & Paes Leme, A. F. Prognostic biomarkers in oral squamous cell carcinoma: a systematic review. Oral. Oncol. 72, 38\u201347 (2017).","journal-title":"Oral. Oncol."},{"key":"233_CR33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.2017.244","volume":"117","author":"A Almangush","year":"2017","unstructured":"Almangush, A. et al. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br. J. Cancer 117, 856\u2013866 (2017).","journal-title":"Br. J. Cancer"},{"key":"233_CR34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00432-006-0111-y","volume":"132","author":"KM Sathyan","year":"2006","unstructured":"Sathyan, K. M. et al. Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J. Cancer Res. Clin. Oncol. 132, 601\u2013609 (2006).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"233_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4149\/neo_2011_03_217","volume":"58","author":"TI Trivedi","year":"2011","unstructured":"Trivedi, T. I. et al. Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma. Neoplasma 58, 217\u2013226 (2011).","journal-title":"Neoplasma"},{"key":"233_CR36","first-page":"2199","volume":"12","author":"HM Mahdey","year":"2011","unstructured":"Mahdey, H. M. et al. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma. Asian Pac. J. Cancer Prev. 12, 2199\u20132204 (2011).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"233_CR37","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/v7031332","volume":"7","author":"T Ramqvist","year":"2015","unstructured":"Ramqvist, T., Grun, N. & Dalianis, T. Human papillomavirus and tonsillar and base of tongue cancer. Viruses 7, 1332\u20131343 (2015).","journal-title":"Viruses"},{"key":"233_CR38","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.ejca.2011.07.006","volume":"47","author":"Y Nakata","year":"2011","unstructured":"Nakata, Y. et al. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Eur. J. Cancer 47, 2364\u20132372 (2011).","journal-title":"Eur. J. Cancer"},{"key":"233_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/00365513.2010.493354","volume":"242","author":"AS Ptolemy","year":"2010","unstructured":"Ptolemy, A. S. & Rifai, N. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand. J. Clin. Lab. Invest. Suppl. 242, 6\u201314 (2010).","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"233_CR40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.bjc.6605544","volume":"102","author":"V Hayry","year":"2010","unstructured":"Hayry, V. et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br. J. Cancer 102, 892\u2013897 (2010).","journal-title":"Br. J. Cancer"},{"key":"233_CR41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.oraloncology.2011.04.017","volume":"47","author":"YJ Liang","year":"2011","unstructured":"Liang, Y. J. et al. Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients. Oral. Oncol. 47, 566\u2013570 (2011).","journal-title":"Oral. Oncol."},{"key":"233_CR42","doi-asserted-by":"crossref","first-page":"BR228","DOI":"10.12659\/MSM.881902","volume":"17","author":"S Theocharis","year":"2011","unstructured":"Theocharis, S. et al. RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. Med. Sci. Monit. 17, BR228\u2013BR234 (2011).","journal-title":"Med. Sci. Monit."},{"key":"233_CR43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2011.03947.x","volume":"59","author":"S Theocharis","year":"2011","unstructured":"Theocharis, S. et al. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival. Histopathology 59, 514\u2013525 (2011).","journal-title":"Histopathology"},{"key":"233_CR44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1600-0714.2011.01031.x","volume":"40","author":"S Theocharis","year":"2011","unstructured":"Theocharis, S. et al. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J. Oral. Pathol. Med. 40, 706\u2013714 (2011).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.oraloncology.2011.06.512","volume":"47","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma. Oral. Oncol. 47, 934\u2013939 (2011).","journal-title":"Oral. Oncol."},{"key":"233_CR46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0714.2011.01110.x","volume":"41","author":"LK Makinen","year":"2012","unstructured":"Makinen, L. K. et al. Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J. Oral. Pathol. Med. 41, 394\u2013399 (2012).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR47","volume":"10","author":"H Li","year":"2012","unstructured":"Li, H. et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J. Transl. Med. 10, 168 (2012).","journal-title":"J. Transl. Med."},{"key":"233_CR48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00432-012-1215-1","volume":"138","author":"S Theocharis","year":"2012","unstructured":"Theocharis, S. et al. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J. Cancer Res. Clin. Oncol. 138, 1369\u20131377 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"233_CR49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/bjc.2012.589","volume":"108","author":"JH Kauppila","year":"2013","unstructured":"Kauppila, J. H., Mattila, A. E., Karttunen, T. J. & Salo, T. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br. J. Cancer 108, 638\u2013643 (2013).","journal-title":"Br. J. Cancer"},{"key":"233_CR50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canep.2012.10.007","volume":"37","author":"ZF Ke","year":"2013","unstructured":"Ke, Z. F. et al. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis. Cancer Epidemiol. 37, 179\u2013185 (2013).","journal-title":"Cancer Epidemiol."},{"key":"233_CR51","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.18632\/oncotarget.1503","volume":"4","author":"Z Li","year":"2013","unstructured":"Li, Z. et al. The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer. Oncotarget 4, 2532\u20132549 (2013).","journal-title":"Oncotarget"},{"key":"233_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/or.2013.2863","volume":"31","author":"H Wen","year":"2014","unstructured":"Wen, H. et al. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma. Oncol. Rep. 31, 169\u2013174 (2014).","journal-title":"Oncol. Rep."},{"key":"233_CR53","first-page":"996","volume":"7","author":"H Li","year":"2014","unstructured":"Li, H. et al. Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer. Int. J. Clin. Exp. Pathol. 7, 996\u20131003 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"233_CR54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12253-013-9692-3","volume":"20","author":"S Theocharis","year":"2014","unstructured":"Theocharis, S. et al. Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Pathol. Oncol. Res. 20, 277\u2013284 (2014).","journal-title":"Pathol. Oncol. Res."},{"key":"233_CR55","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/bjc.2014.178","volume":"110","author":"M Toyoda","year":"2014","unstructured":"Toyoda, M. et al. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br. J. Cancer 110, 2506\u20132513 (2014).","journal-title":"Br. J. Cancer"},{"key":"233_CR56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jop.12143","volume":"43","author":"L Ding","year":"2014","unstructured":"Ding, L. et al. alpha-smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J. Oral. Pathol. Med. 43, 335\u2013343 (2014).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR57","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.7314\/APJCP.2014.15.19.8351","volume":"15","author":"V Ramshankar","year":"2014","unstructured":"Ramshankar, V., Soundara, V. T., Shyamsundar, V., Ramani, P. & Krishnamurthy, A. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac. J. Cancer Prev. 15, 8351\u20138359 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"233_CR58","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1007\/s13277-014-1853-9","volume":"35","author":"S Theocharis","year":"2014","unstructured":"Theocharis, S. et al. Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Tumour Biol. 35, 6455\u20136465 (2014).","journal-title":"Tumour Biol."},{"key":"233_CR59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/his.12441","volume":"65","author":"C Yuan","year":"2014","unstructured":"Yuan, C. et al. Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer. Histopathology 65, 595\u2013605 (2014).","journal-title":"Histopathology"},{"key":"233_CR60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jop.12220","volume":"44","author":"C Yuan","year":"2015","unstructured":"Yuan, C. et al. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer. J. Oral. Pathol. Med. 44, 159\u2013165 (2015).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR61","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0357-6","volume":"14","author":"G Zheng","year":"2015","unstructured":"Zheng, G. et al. ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH. Mol. Cancer 14, 84 (2015).","journal-title":"Mol. Cancer"},{"key":"233_CR62","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/hed.23627","volume":"37","author":"N Kelner","year":"2015","unstructured":"Kelner, N. et al. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head. Neck 37, 479\u2013486 (2015).","journal-title":"Head. Neck"},{"key":"233_CR63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jop.12245","volume":"44","author":"M Aparna","year":"2015","unstructured":"Aparna, M., Rao, L., Kunhikatta, V. & Radhakrishnan, R. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J. Oral. Pathol. Med. 44, 345\u2013352 (2015).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR64","volume":"13","author":"H Li","year":"2015","unstructured":"Li, H. et al. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer. J. Transl. Med. 13, 198 (2015).","journal-title":"J. Transl. Med."},{"key":"233_CR65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12253-014-9891-6","volume":"21","author":"N Imayama","year":"2015","unstructured":"Imayama, N. et al. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma. Pathol. Oncol. Res. 21, 783\u2013791 (2015).","journal-title":"Pathol. Oncol. Res."},{"key":"233_CR66","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3892\/ol.2015.3496","volume":"10","author":"F Hu","year":"2015","unstructured":"Hu, F. et al. Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma. Oncol. Lett. 10, 1303\u20131308 (2015).","journal-title":"Oncol. Lett."},{"key":"233_CR67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jop.12272","volume":"44","author":"JH Kauppila","year":"2015","unstructured":"Kauppila, J. H. et al. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. J. Oral. Pathol. Med. 44, 571\u2013577 (2015).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.oooo.2015.06.002","volume":"120","author":"T Matsui","year":"2015","unstructured":"Matsui, T., Shigeta, T., Umeda, M., & Komori, T. Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 120, 436\u2013442 (2015).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"233_CR69","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3892\/ol.2015.3565","volume":"10","author":"T Naruse","year":"2015","unstructured":"Naruse, T. et al. Immunohistochemical study of vascular endothelial growth factor-C\/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: correlation with the induction of lymphangiogenesis. Oncol. Lett. 10, 2027\u20132034 (2015).","journal-title":"Oncol. Lett."},{"key":"233_CR70","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s13277-015-4182-8","volume":"37","author":"S Theocharis","year":"2016","unstructured":"Theocharis, S. et al. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients\u2019 survival. Tumour Biol. 37, 3647\u20133656 (2016).","journal-title":"Tumour Biol."},{"key":"233_CR71","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3892\/or.2016.5116","volume":"36","author":"H Al-Shareef","year":"2016","unstructured":"Al-Shareef, H. et al. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue. Oncol. Rep. 36, 2444\u20132454 (2016).","journal-title":"Oncol. Rep."},{"key":"233_CR72","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1007\/s00405-016-3964-y","volume":"273","author":"I Heikkinen","year":"2016","unstructured":"Heikkinen, I. et al. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study. Eur. Arch. Otorhinolaryngol. 273, 3905\u20133911 (2016).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"233_CR73","volume":"14","author":"XP Zhao","year":"2016","unstructured":"Zhao, X. P. et al. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. J. Transl. Med. 14, 26 (2016).","journal-title":"J. Transl. Med."},{"key":"233_CR74","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.18632\/oncotarget.13763","volume":"8","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway. Oncotarget 8, 3344\u20133354 (2017).","journal-title":"Oncotarget"},{"key":"233_CR75","volume":"17","author":"H Hu","year":"2017","unstructured":"Hu, H. et al. Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma. Cancer Cell. Int. 17, 26 (2017).","journal-title":"Cancer Cell. Int."},{"key":"233_CR76","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2016.08.022","volume":"75","author":"S Theocharis","year":"2017","unstructured":"Theocharis, S. et al. Phosphorylated epidermal growth factor receptor expression is associated with clinicopathologic parameters and patient survival in mobile tongue squamous cell carcinoma. J. Oral. Maxillofac. Surg. 75, 632\u2013640 (2017).","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"233_CR77","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00016489.2017.1292049","volume":"137","author":"E Lindell Jonsson","year":"2017","unstructured":"Lindell Jonsson, E., Nylander, K., Hallen, L. & Laurell, G. Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0. Acta Otolaryngol. 137, 877\u2013882 (2017).","journal-title":"Acta Otolaryngol."},{"key":"233_CR78","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijom.2017.03.035","volume":"46","author":"HS Ong","year":"2017","unstructured":"Ong, H. S. et al. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients. Int. J. Oral. Maxillofac. Surg. 46, 1205\u20131219 (2017).","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"233_CR79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1245\/s10434-011-2052-1","volume":"19","author":"K Sakamoto","year":"2012","unstructured":"Sakamoto, K. et al. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I\/II oral tongue squamous cell carcinoma after partial glossectomy. Ann. Surg. Oncol. 19, 612\u2013619 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"233_CR80","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/ijc.26226","volume":"130","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer 130, 2249\u20132258 (2012).","journal-title":"Int. J. Cancer"},{"key":"233_CR81","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.oraloncology.2012.06.010","volume":"48","author":"S Albert","year":"2012","unstructured":"Albert, S. et al. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral. Oncol. 48, 1263\u20131271 (2012).","journal-title":"Oral. Oncol."},{"key":"233_CR82","doi-asserted-by":"crossref","first-page":"e0178581","DOI":"10.1371\/journal.pone.0178581","volume":"12","author":"PF Liu","year":"2017","unstructured":"Liu, P. F. et al. Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins. PLoS ONE 12, e0178581 (2017).","journal-title":"PLoS ONE"},{"key":"233_CR83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.oraloncology.2010.11.014","volume":"47","author":"X Liang","year":"2011","unstructured":"Liang, X. et al. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral. Oncol. 47, 92\u201397 (2011).","journal-title":"Oral. Oncol."},{"key":"233_CR84","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2559.2011.04130.x","volume":"60","author":"C Huang","year":"2012","unstructured":"Huang, C. et al. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 60, 793\u2013803 (2012).","journal-title":"Histopathology"},{"key":"233_CR85","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/hed.21945","volume":"34","author":"MW Han","year":"2012","unstructured":"Han, M. W. et al. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head. Neck 34, 1395\u20131402 (2012).","journal-title":"Head. Neck"},{"key":"233_CR86","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3892\/etm.2012.779","volume":"5","author":"FW Kang","year":"2013","unstructured":"Kang, F. W., Gao, Y., Que, L., Sun, J. & Wang, Z. L. Hypoxia-inducible factor-1alpha overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma. Exp. Ther. Med. 5, 112\u2013118 (2013).","journal-title":"Exp. Ther. Med."},{"key":"233_CR87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.oraloncology.2011.05.017","volume":"47","author":"L Du","year":"2011","unstructured":"Du, L. et al. Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral. Oncol. 47, 709\u2013713 (2011).","journal-title":"Oral. Oncol."},{"key":"233_CR88","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/jop.12159","volume":"43","author":"CF Huang","year":"2014","unstructured":"Huang, C. F., Xu, X. R., Wu, T. F., Sun, Z. J. & Zhang, W. F. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. J. Oral. Pathol. Med. 43, 492\u2013498 (2014).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.oooo.2013.09.007","volume":"117","author":"Z Fang","year":"2014","unstructured":"Fang, Z. et al. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 117, 89\u201395 (2014).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"233_CR90","first-page":"405860","volume":"2014","author":"W Gao","year":"2014","unstructured":"Gao, W., Chan, J. Y. & Wong, T. S. Long non-coding RNA deregulation in tongue squamous cell carcinoma. Biomed. Res. Int. 2014, 405860 (2014).","journal-title":"Biomed. Res. Int."},{"key":"233_CR91","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ijc.28667","volume":"135","author":"LF Jia","year":"2014","unstructured":"Jia, L. F. et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int. J. Cancer 135, 2282\u20132293 (2014).","journal-title":"Int. J. Cancer"},{"key":"233_CR92","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1007\/s13277-015-3645-2","volume":"36","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumour Biol. 36, 8805\u20138809 (2015).","journal-title":"Tumour Biol."},{"key":"233_CR93","doi-asserted-by":"crossref","first-page":"62520","DOI":"10.18632\/oncotarget.11528","volume":"7","author":"W Huang","year":"2016","unstructured":"Huang, W. et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Oncotarget 7, 62520\u201362532 (2016).","journal-title":"Oncotarget"},{"key":"233_CR94","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jop.12599","volume":"46","author":"ZQ Li","year":"2017","unstructured":"Li, Z. Q., Zou, R., Ouyang, K. X. & Ai, W. J. An in vitro study of the long non-coding RNA TUG1 in tongue squamous cell carcinoma. J. Oral. Pathol. Med. 46, 956\u2013960 (2017).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.joms.2016.08.009","volume":"75","author":"KX Ouyang","year":"2017","unstructured":"Ouyang, K. X. et al. TUC338 overexpression leads to enhanced proliferation and reduced apoptosis in tongue squamous cell carcinoma cells in vitro. J. Oral. Maxillofac. Surg. 75, 423\u2013428 (2017).","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"233_CR96","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/jca.17510","volume":"8","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. J. Cancer 8, 523\u2013530 (2017).","journal-title":"J. Cancer"},{"key":"233_CR97","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.18632\/oncotarget.14200","volume":"8","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. Oncotarget 8, 16621\u201316632 (2017).","journal-title":"Oncotarget"},{"key":"233_CR98","volume":"16","author":"Z Fang","year":"2016","unstructured":"Fang, Z. et al. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins. BMC Cancer 16, 706 (2016).","journal-title":"BMC Cancer"},{"key":"233_CR99","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3892\/or.2017.5445","volume":"37","author":"TH Zhang","year":"2017","unstructured":"Zhang, T. H. et al. Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1. Oncol. Rep. 37, 2087\u20132094 (2017).","journal-title":"Oncol. Rep."},{"key":"233_CR100","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00005537-200009000-00012","volume":"110","author":"G Hartig","year":"2000","unstructured":"Hartig, G. et al. Fluorescent in situ hybridizaton evaluation of p53 gene deletions at a tumor interface of lingual carcinoma. Laryngoscope 110, 1474\u20131478 (2000).","journal-title":"Laryngoscope"},{"key":"233_CR101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3835(01)00651-6","volume":"172","author":"M Fujii","year":"2001","unstructured":"Fujii, M., Ishiguro, R., Yamashita, T. & Tashiro, M. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett. 172, 187\u2013192 (2001).","journal-title":"Cancer Lett."},{"key":"233_CR102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1368-8375(01)00121-X","volume":"38","author":"H Goto","year":"2002","unstructured":"Goto, H., Kawano, K., Kobayashi, I., Sakai, H. & Yanagisawa, S. Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral. Oncol. 38, 549\u2013556 (2002).","journal-title":"Oral. Oncol."},{"key":"233_CR103","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.oraloncology.2003.09.011","volume":"40","author":"EJ Hannen","year":"2004","unstructured":"Hannen, E. J. et al. Different chromosomal imbalances in metastasized and nonmetastasized tongue carcinomas identified by comparative genomic hybridization. Oral. Oncol. 40, 364\u2013371 (2004).","journal-title":"Oral. Oncol."},{"key":"233_CR104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anl.2007.12.002","volume":"35","author":"Y Shimizu","year":"2008","unstructured":"Shimizu, Y., Kondo, S., Shirai, A., Furukawa, M. & Yoshizaki, T. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35, 381\u2013389 (2008).","journal-title":"Auris Nasus Larynx"},{"key":"233_CR105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0714.2007.00603.x","volume":"37","author":"F Angiero","year":"2008","unstructured":"Angiero, F. et al. Comparative analysis of c-erbB-2 (HER-2\/neu) in squamous cell carcinoma of the tongue: does over-expression exist? And what is its correlation with traditional diagnostic parameters? J. Oral. Pathol. Med. 37, 145\u2013150 (2008).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR106","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2009.02.027","volume":"45","author":"M Ryott","year":"2009","unstructured":"Ryott, M. et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur. J. Cancer 45, 1700\u20131708 (2009).","journal-title":"Eur. J. Cancer"},{"key":"233_CR107","first-page":"525","volume":"39","author":"C Prapinjumrune","year":"2010","unstructured":"Prapinjumrune, C. et al. DNA amplification and expression of FADD in oral squamous cell carcinoma. J. Oral. Pathol. Med. 39, 525\u2013532 (2010).","journal-title":"J. Oral. Pathol. Med."},{"key":"233_CR108","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejca.2009.10.018","volume":"46","author":"J Aida","year":"2010","unstructured":"Aida, J. et al. Telomere lengths in the oral epithelia with and without carcinoma. Eur. J. Cancer 46, 430\u2013438 (2010).","journal-title":"Eur. J. Cancer"},{"key":"233_CR109","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1601-0825.2011.01838.x","volume":"17","author":"G Supic","year":"2011","unstructured":"Supic, G., Kozomara, R., Jovic, N., Zeljic, K. & Magic, Z. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral. Dis. 17, 794\u2013800 (2011).","journal-title":"Oral. Dis."},{"key":"233_CR110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.oraloncology.2013.01.006","volume":"49","author":"RJ Young","year":"2013","unstructured":"Young, R. J. et al. Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome. Oral. Oncol. 49, 576\u2013581 (2013).","journal-title":"Oral. Oncol."},{"key":"233_CR111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/gtmb.2012.0210","volume":"17","author":"LV Mostaan","year":"2013","unstructured":"Mostaan, L. V. et al. Survivin gene polymorphism association with tongue squamous cell carcinoma. Genet. Test. Mol. Biomark. 17, 74\u201377 (2013).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"233_CR112","doi-asserted-by":"crossref","first-page":"e114002","DOI":"10.1371\/journal.pone.0114002","volume":"9","author":"RS Adduri","year":"2014","unstructured":"Adduri, R. S. et al. TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India. PLoS ONE 9, e114002 (2014).","journal-title":"PLoS ONE"},{"key":"233_CR113","volume":"14","author":"DS Tan","year":"2014","unstructured":"Tan, D. S. et al. Tongue carcinoma infrequently harbor common actionable genetic alterations. BMC Cancer 14, 679 (2014).","journal-title":"BMC Cancer"},{"key":"233_CR114","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.28727","volume":"135","author":"AM Lim","year":"2014","unstructured":"Lim, A. M. et al. Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome. Int. J. Cancer 135, 887\u2013895 (2014).","journal-title":"Int. J. Cancer"},{"key":"233_CR115","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/gcc.22395","volume":"55","author":"T Morita","year":"2016","unstructured":"Morita, T. et al. Characterizing genetic transitions of copy number alterations and allelic imbalances in oral tongue carcinoma metastasis. Genes Chromosomes Cancer 55, 975\u2013986 (2016).","journal-title":"Genes Chromosomes Cancer"},{"key":"233_CR116","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijom.2017.03.001","volume":"46","author":"T Kakuya","year":"2017","unstructured":"Kakuya, T. et al. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer. Int. J. Oral. Maxillofac. Surg. 46, 968\u2013976 (2017).","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"233_CR117","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0964-1955(96)00022-X","volume":"32B","author":"S Atula","year":"1996","unstructured":"Atula, S., Kurvinen, K., Grenman, R. & Syrjanen, S. SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer. Eur. J. Cancer B. Oral. Oncol. 32B, 222\u2013229 (1996).","journal-title":"Eur. J. Cancer B. Oral. Oncol."},{"key":"233_CR118","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1002\/lary.24595","volume":"124","author":"CM Heaton","year":"2014","unstructured":"Heaton, C. M., Durr, M. L., Tetsu, O., van Zante, A. & Wang, S. J. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope 124, E267\u2013E273 (2014).","journal-title":"Laryngoscope"},{"key":"233_CR119","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6890-14-37","volume":"14","author":"R Adduri","year":"2014","unstructured":"Adduri, R. et al. P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue. BMC Clin. Pathol. 14, 37 (2014).","journal-title":"BMC Clin. Pathol."},{"key":"233_CR120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.12688\/f1000research.7302.1","volume":"4","author":"N Krishnan","year":"2015","unstructured":"Krishnan, N. et al. Integrated analysis of oral tongue squamous cell carcinoma identifies key variants and pathways linked to risk habits, HPV, clinical parameters and tumor recurrence. F1000Res. 4, 1215 (2015).","journal-title":"F1000Res."},{"key":"233_CR121","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0219-2","volume":"7","author":"AL Vettore","year":"2015","unstructured":"Vettore, A. L. et al. Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance. Genome Med. 7, 98 (2015).","journal-title":"Genome Med."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0233-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T08:16:21Z","timestamp":1720512981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0233-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0233-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No funding other than institutional funding was received","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}